HCAR
Healthcare Services Acquisition Corporation [HCAR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HCAR Stock Summary
In the News
HCAR Financial details
Company Rating
Neutral
Market Cap
418.14M
Income
14.98M
Revenue
0
Book val./share
-0.41
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
29 Mar 2021
P/E
27.3
Forward P/E
-
PEG
-0.02
P/S
-
P/B
-24.71
P/C
-
P/FCF
-352.73
Quick Ratio
0.13
Current Ratio
0.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.36
EPS next Y
-
EPS next Q
-
EPS this Y
-8766.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-53.08%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
4%
ROE
-69%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
33.12M
Shs Float
30.05M
-
-
-
-
Target Price
-
52W Range
9.7099-10.11
52W High
-100%
52W Low
-100%
RSI
0.5
Rel Volume
-
Avg Volume
140.71K
Volume
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 4.86%
Prev Close
-
Price
0
Change
-
HCAR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2021-12-31 |
|---|---|---|
| Revenue per share | 0 | |
| Net income per share | 0.26 | |
| Operating cash flow per share | -0.02 | |
| Free cash flow per share | -0.02 | |
| Cash per share | 0.02 | |
| Book value per share | -0.66 | |
| Tangible book value per share | 7.34 | |
| Share holders equity per share | -0.66 | |
| Interest debt per share | 0 | |
| Market cap | 402.53M | |
| Enterprise value | 401.79M | |
| P/E ratio | 37.92 | |
| Price to sales ratio | 0 | |
| POCF ratio | -443.07 | |
| PFCF ratio | -443.07 | |
| P/B Ratio | -14.7 | |
| PTB ratio | -14.7 | |
| EV to sales | 0 | |
| Enterprise value over EBITDA | 0 | |
| EV to operating cash flow | -442.25 | |
| EV to free cash flow | -442.25 | |
| Earnings yield | 0.03 | |
| Free cash flow yield | 0 | |
| Debt to equity | 0 | |
| Debt to assets | 0.09 | |
| Net debt to EBITDA | 0 | |
| Current ratio | 4.19 | |
| Interest coverage | 0 | |
| Income quality | -0.09 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0 | |
| Capex to operating cash flow | 0 | |
| Capex to revenue | 0 | |
| Capex to depreciation | 0 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 1.95 | |
| ROIC | -0.01 | |
| Return on tangible assets | 0.03 | |
| Graham Net | -0.67 | |
| Working capital | 743.82K | |
| Tangible asset value | 0 | |
| Net current asset value | -27.45M | |
| Invested capital | 0 | |
| Average receivables | 0 | |
| Average payables | 40.45K | |
| Average inventory | 0 | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 0 | |
| Days of inventory on hand | 0 | |
| Receivables turnover | 0 | |
| Payables turnover | 0 | |
| Inventory turnover | 0 | |
| ROE | -0.39 | |
| Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0.11 | 0.08 | 0.09 | 0.13 | 0.06 | |
| Operating cash flow per share | 0 | -0.01 | -0.01 | -0.01 | 0 | |
| Free cash flow per share | 0 | -0.01 | -0.01 | -0.01 | 0 | |
| Cash per share | 0.01 | 0.02 | 0.01 | 0.01 | 0 | |
| Book value per share | -0.74 | -0.66 | -0.57 | -0.45 | -0.41 | |
| Tangible book value per share | 7.26 | 7.34 | 7.43 | 7.56 | 7.62 | |
| Share holders equity per share | -0.74 | -0.66 | -0.57 | -0.45 | -0.41 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 403.65M | 404.06M | 405.72M | 407.38M | 411.1M | |
| Enterprise value | 403.23M | 403.32M | 405.4M | 407.09M | 411.03M | |
| P/E ratio | 21.35 | 29.82 | 27.61 | 18.9 | 40.67 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -2.6K | -1.38K | -920.61 | -1.66K | -1.99K | |
| PFCF ratio | -2.6K | -1.38K | -920.61 | -1.66K | -1.99K | |
| P/B Ratio | -13.12 | -14.76 | -17.11 | -22.05 | -24.29 | |
| PTB ratio | -13.12 | -14.76 | -17.11 | -22.05 | -24.29 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 85.32 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | -2.6K | -1.38K | -919.87 | -1.66K | -1.99K | |
| EV to free cash flow | -2.6K | -1.38K | -919.87 | -1.66K | -1.99K | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0.09 | 0.09 | 0.07 | 0.06 | 0.05 | |
| Net debt to EBITDA | -0.09 | 0 | 0 | 0 | 0 | |
| Current ratio | 2.69 | 4.19 | 2.83 | 2.23 | 0.3 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | -0.03 | -0.09 | -0.12 | -0.05 | -0.08 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.38 | 1.1 | 1.07 | 1.14 | 0.75 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Graham Net | -0.75 | -0.67 | -0.58 | -0.46 | -0.43 | |
| Working capital | 453.9K | 743.82K | 394.7K | 262.04K | -408.29K | |
| Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
| Net current asset value | -30.81M | -27.45M | -23.8M | -18.69M | -17.56M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 83.94K | 85.11K | 85.5K | 98.13K | 70.93K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.15 | -0.12 | -0.15 | -0.29 | -0.15 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
HCAR Frequently Asked Questions
What is Healthcare Services Acquisition Corporation stock symbol ?
Healthcare Services Acquisition Corporation is a US stock , located in Bethesda of Md and trading under the symbol HCAR
Is Healthcare Services Acquisition Corporation stock public?
Yes, Healthcare Services Acquisition Corporation is a publicly traded company.
Company Profile
- Volume Average 140.71K
- Market Capitalization 418.14M
- CEO Mr. Joshua B. Lynn
- Headquarters Bethesda,MD,US
- IPO Date 2021-01-05
-
Website
https://www.healthcarespac.com 
Healthcare Services Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Healthcare Services Acquisition Corporation was incorporated in 2020 and is based in Bethesda, Maryland.
